Articles
Page 337 of 346
-
Citation: Critical Care 1999 2:2422
-
Ramipril reduces mortality in patients at high risk of heart failure
Citation: Critical Care 1999 2:2401 -
Cerebral oxygen saturation measured by near-infrared spectroscopy and jugular oxygen saturation
Citation: Critical Care 1999 1:2361 -
Web site featuring complete books
Citation: Critical Care 1999 3:webreport102 -
1999 Additions to the SCCM Guidelines & Practice Parameters
Citation: Critical Care 1999 3:webreport101 -
Angioplasty versus thrombolysis for AMI
Citation: Critical Care 1999 1:2381 -
Can we affect outcome following head injury?
Citation: Critical Care 1999 1:2342 -
Continuous plasmafiltration in sepsis syndrome
Citation: Critical Care 1999 2:2343 -
Hypothermia in acute liver failure
Citation: Critical Care 1999 2:2322 -
Hyperthermic preconditioning
Citation: Critical Care 1999 2:2341 -
Review: hypercapnia and the critically ill
Citation: Critical Care 1999 2:2321 -
Endotracheal tube and VAP
Citation: Critical Care 1999 2:2301 -
TISS to predict mortality
Citation: Critical Care 1999 2:2302 -
Protective effect of pancreatitis-associated protein
Citation: Critical Care 1999 2:2282 -
Dobutamine in the postbypass period
Citation: Critical Care 1999 2:2261 -
Experience with prolonged induced hypothermia in severe head injury
Citation: Critical Care 1999 3:R105 -
Risk factors for prolonged emergence from fast track cardiac anaesthesia
Citation: Critical Care 1999 2:2242 -
High perioperative FiO2and absorption atelectasis
Citation: Critical Care 1999 2:2222 -
Unintended inhalation of nitric oxide by contamination of compressed air
Citation: Critical Care 1999 2:2221 -
Exercise testing to predict mortality
Citation: Critical Care 1999 2:2241 -
Catecholamine-induced interleukin-10 release: a key mechanism in systemic immunodepression after brain injury
Infections after severe brain injury or polytrauma are still a problem, and may be the result of a brain-mediated disturbed systemic immunoreactivity. The mechanism that connects initial brain affection and sy...
Citation: Critical Care 1999 3:R107 -
NIV for weaning
Citation: Critical Care 1999 1:2201 -
Further benefits of norepinephrine in septic shock
Citation: Critical Care 1999 1:2161 -
Paper reports: Combating the invasion of intensive care literature
Citation: Critical Care 1999 3:P61 -
New additions to Infectious Disease
Citation: Critical Care 1999 3:webreport421 -
Chest X-rays after central line insertion
Citation: Critical Care 1999 2:2182 -
A new nosocomial danger?
Citation: Critical Care 1999 2:2163 -
Lorazepam for ICU sedation
Citation: Critical Care 1999 2:2162 -
Liposomal delivery of protein 72
Citation: Critical Care 1999 2:2141 -
Mivazerol may reduce cardiac risk in vascular surgical patients
Citation: Critical Care 1999 2:2121 -
Nitric oxide in ALI
Citation: Critical Care 1999 2:2181 -
Low molecular weight heparin reduces the incidence of deep venous thrombosis in high-risk medical patients
Citation: Critical Care 1999 2:1121 -
Increasing afterload induces myocardial diastolic dysfunction
Citation: Critical Care 1999 2:2081 -
Regional dissemination of VRE by interfacility transfer
Citation: Critical Care 1999 2:2041 -
H-CSF in the ICU
Citation: Critical Care 1999 2:2101 -
U/S-aided thoracentesis in the ICU
Citation: Critical Care 1999 2:2061 -
Abdominal compartment syndrome
Citation: Critical Care 1999 3:R103 -
GH treatment for the critically ill
Citation: Critical Care 1999 1:2021 -
Blood substitutes: Haemoglobin therapeutics in clinical practice
Early approaches to the development of oxygen carriers involved the use of stroma-free hemoglobin solutions. These solutions did not require blood typing or crossmatching and could be stored for long periods. ...
Citation: Critical Care 1999 3:R99 -
Active compression-decompression improves outcome after cardiac arrest
Citation: Critical Care 1999 1:1881 -
SIDS Network
Citation: Critical Care 1999 3:webreport401 -
Blood substitutes Artificial oxygen carriers: perfluorocarbon emulsions
Perfluorocarbon emulsions are being clinically evaluated as artificial oxygen carriers to reduce allogeneic blood transfusions or to improve tissue oxygenation. Perfluorocarbon emulsions are efficacious in ani...
Citation: Critical Care 1999 3:R93 -
Blood substitutes
Citation: Critical Care 1999 3:R91 -
Equipment review: Intrahospital transport of critically ill patients
This review on the current literature of the intrahospitaltransport of critically ill patients addresses type and incidence of adverseeffects, risk factors and risk assessment, and the available information on...
Citation: Critical Care 1999 3:R83 -
Equipment review: Mechanical effects of heat-moisture exchangers in ventilated patients
Although they represent a valuable alternative to heated humidifiers, artificial noses have unfavourable mechanical effects. Most important of these is the increase in dead space, with consequent increase in t...
Citation: Critical Care 1999 3:R77 -
Revascularization versus medical therapy for the treatment of cardiogenic shock
Citation: Critical Care 1999 1:1761 -
Measuring Quality of Life
Citation: Critical Care 1999 3:webreport381 -
Nutrition in the intensive care unit
Nutritional support has become a routine part of the care of the critically ill patient. It is an adjunctive therapy, the main goal of which is to attenuate the development of malnutrition, yet the effectivene...
Citation: Critical Care 1999 3:R67 -
N-acetylcysteine to prevent multisystem organ failure
Citation: Critical Care 1999 2:1442 -
ACC/AHA 1999 Updated Guidelines for the Management of Patients with Acute Myocardial Infarction (AMI)
Citation: Critical Care 1999 3:webreport341
Follow
- ISSN: 1364-8535 (electronic)